Zinc diet and Alzheimer's disease: a systematic review

@article{Loef2012ZincDA,
  title={Zinc diet and Alzheimer's disease: a systematic review},
  author={Martin Loef and Nikolaus von Stillfried and Harald Walach},
  journal={Nutritional Neuroscience},
  year={2012},
  volume={15},
  pages={12 - 2}
}
Abstract Objectives This paper reviews evidence of an association between zinc (Zn) nutrition and Alzheimer's disease (AD) or age-associated cognitive decline. The involvement of zinc in the pathology of AD has been reported hundreds of times. It is, however, still a matter of debate whether the disease progression can be influenced by modifying zinc in the diet. Methods We searched Medline, Embase, Biosis, ALOIS, the Cochrane central register of controlled trials, the Cochrane database of… 
Alzheimer's disease and diet: a systematic review
TLDR
The finding that 50 of the 64 reviewed studies revealed an association between diet and AD incidence offers promising implications for diet as a modifiable risk factor for AD.
Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies.
TLDR
The meta-analysis of serum data showed that AD patients have higher levels of serum Cu than healthy controls, and the analysis of CSF data revealed no difference between AD patients and controls.
Factors Associated with Alzheimer’s Disease: An Overview of Reviews
TLDR
Better knowledge of risk factors for AD allows for better identification of patients at risk, and may contribute to the emergence of prevention policies to delay or prevent the onset of AD.
Alzheimer's Disease-Current Status and Future Directions.
TLDR
This review article focuses on the various genetic and other predisposing factors that account for AD, pathophysiology of the disease, and the mechanisms by which Aβ plaques and NFTs are formed and could affect AD brain.
Alzheimer's Disease-Current Status and Future Directions.
TLDR
The various genetic and other predisposing factors that account for AD, pathophysiology of the disease, and the mechanisms by which Aβ plaques and NFTs are formed and could affect AD brain are focused on.
Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer's disease pathology?
TLDR
A greater understanding of AD pathophysiology is paramount, and attention is now being directed to the discovery of biomarkers that may not only facilitate pre-symptomatic diagnosis, but also provide an insight into aberrant biochemical pathways that may reveal potential therapeutic targets, including nutritional ones.
Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
TLDR
A literature review on the major nutrients that are related to AD, including selenium, vitamins C and E, transition metals, vitamin D, B-complex vitamins, and omega-3 fatty acids is performed.
Zinc.
Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
TLDR
This review will focus on the human clinical intervention trials that have been conducted over approximately the last four decades that have attempted to establish the efficacy of targeting metal ions in the treatment of AD.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 149 REFERENCES
Copper and iron in Alzheimer's disease: a systematic review and its dietary implications
TLDR
It is suggested that diets excessive in Fe or Cu, together with a high intake of SFA, should be avoided in the elderly who are not at risk of anaemia.
Selenium and Alzheimer's disease: a systematic review.
TLDR
The current state of knowledge provides no evidence for a role of Se in the treatment of AD, but allows speculation on a potential preventive relevance, and large trials of long-term duration could provide definitive answers.
Metal protein attenuating compounds for the treatment of Alzheimer's dementia.
TLDR
There is an absence of evidence as to whether clioquinol (PBT1) has any positive clinical benefit for patients with AD, or whether the drug is safe, and there is some concerns about the quality of the study methodology.
Metal protein attenuating compounds for the treatment of Alzheimer's disease.
TLDR
There is an absence of evidence as to whether clioquinol (PBT1) has any positive clinical benefit for patients with AD, or whether the drug is safe, and there are concerns about the quality of the study methodology.
Can nutrients prevent or delay onset of Alzheimer's disease?
TLDR
The literature reinforces the need for early intervention in AD and suggests that multi-nutritional intervention, targeting multiple aspects of the neurodegenerative process during the earliest possible phase in the development of the disease, is likely to have the greatest therapeutic potential.
Serum zinc in the progression of Alzheimer's disease.
TLDR
A significant decrease of serum Zn is suggested in men with MCI, which may explain the loss of ZnT-1 observed in previous studies and suggest there may be more pronounced sex differences in MCI than were previously recognized.
Clioquinol for the treatment of Alzheimer's Disease.
TLDR
It is not clear from the trial that clioquinol shows any positive clinical result on patients with AD, but two statistically significant positive results were seen for the more severely affected subgroup of patients and this effect was not maintained at the 36 week end-point.
Methods of assessment of zinc status in humans: a systematic review.
TLDR
This systematic review confirms that in healthy individuals, plasma, urinary, and hair zinc are reliable biomarkers of zinc status, and further high-quality studies are required, particularly in infants, adolescents, and immigrant population groups for whom there are limited data.
...
1
2
3
4
5
...